Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00991315
Recruitment Status :
(Specimens are now collected through the BRS protocol.)
First Posted : October 8, 2009
Last Update Posted : April 8, 2021
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
Rutgers Cancer Institute of New Jersey
Information provided by (Responsible Party):
Isaac Yi Kim, MD, PhD, MBA, Rutgers, The State University of New Jersey
The primary objective of this study is to collect material for study's to assess mechanisms of tumor progression, mechanisms of resistance, isolation of stem cells and biologic markers in tissue, serum and peripheral blood mononuclear cells.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Any patient undergoing a routine prostatectomy or TURP (transurethral resection of the prostate) may be asked to participate
Undergoing routine prostatectomy or transurethral resection of the prostate (TURP)
5.1.1 Patient is undergoing routine prostatectomy or TURP.